# SUCRALFATE
> **ANDA215576** · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL PHARMS · Approved 2022-04-15
## Drug
- **FDA Application Number:** ANDA215576
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SUCRALFATE
- **Generic name:** SUCRALFATE
- **Active ingredients:** SUCRALFATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AMNEAL PHARMS
- **Manufacturer:** Amneal Pharmaceuticals NY LLC
- **First approval:** 2022-04-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215576)
---
*AI Analytics · CC0 1.0*